International Journal of Cardiology
Publisher: Elsevier · ISSN 0167-5273 · 80 articles
- The triglyceride-glucose index and intramyocardial hemorrhage identify a high-risk phenotype in STEMI
- Multimodality imaging for predicting regional wall motion recovery after percutaneous coronary intervention for chronic total occlusion
- Coronary vascular dysfunction is associated with adverse left ventricular filling in patients with angina but no obstructed coronary arteries
- Pressure-volume loop reconstruction of Impella support in severe aortic regurgitation: explaining a hemodynamic paradox
- Temporal trends and outcomes of intravascular imaging in chronic total occlusion interventions: insights from the PROGRESS-CTO registry
- GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study
- The value of less: Rethinking heart failure therapy after effective rhythm control in AF-mediated cardiomyopathy
- Clinical phenotypes, outcomes, and myocardial transcriptomic signatures in inflammatory myocardial disease: A prospective cohort study
- Prognostic value of early post-admission pan-immune-inflammation value in Takotsubo syndrome
- Coronary microvascular dysfunction in takotsubo syndrome: An interventional perspective on pathophysiology, diagnostic workflow and prognosis
- Persistent C-reactive protein elevation and heart failure: Risk marker, mediator, or therapeutic target?
- Raising diagnoses or doubts? RAISE score for transthyretin cardiac amyloidosis identification in aortic stenosis
- CA125 and the right ventricle in acute heart failure: A marker of dysfunction or congestion?
- Towards the diagnostic scores we need in ATTR-CM: Editorial for the article: Comparison of three scoring systems in the identification of transthyretin cardiac amyloidosis in a HFpEF cohort
- Reply to: “Left ventricular outflow tract obstruction and myocardial edema burden in Takotsubo syndrome: acute and long-term outcomes—insights from the EVOLUTION registry”
- Left atrial dimension and new-onset atrial fibrillation in chronic Chagas disease: a competing-risk analysis of the SEARCH-Rio cohort - Addendum"-Benchimol-Barbosa PR, Benchimol-Barbosa ACL, Kantharia BK.: Response to Letter to the Editor “Beyond Left Atrial Diameter in Chagas Disease: Interatrial Block and Competing-Risk Modelling for Atrial Fibrillation Risk” by Ullah T and Shah MT
- Response to: “Circulating MBL after acute coronary syndrome: Refining the path from biomarker to mechanism”
- Advanced right heart failure stage at first documentation of severe tricuspid regurgitation: beyond the late-referral paradigm
- Left bundle branch block: A marker before, a mediator of heart failure after aortic valve replacement?
- Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone in intermediate–high risk pulmonary embolism
- Associations of PM2.5 components with dynamic and accelerated progression of different kidney function states and subsequent cardiovascular events: The GOLD-Health cohort
- QTc reference ranges in eastern European children aged 6 to 18 years: a large-scale population study and comparison with international normative datasets
- Association of circumferential dissection on computed tomography angiography with preoperative rupture in type A aortic dissection
- Late gadolinium enhancement dispersion mapping predicts major arrhythmic events in patients with prior myocardial infarction
- Reversible wall motion abnormalities do not predict long-term mortality if coronary flow reserve is accounted for: A 15-year contrast stress-echo study
- Democratizing AI-assisted bedside echocardiography: Why governance and workflow matter more than the machine
- Beyond scar burden: does myocardial scar heterogeneity refine arrhythmic risk stratification after myocardial infarction
- Beyond the resting ECG: Towards a more personalized approach to cardiovascular screening in elite athletes
- Positive-call rates and agreement of two artificial intelligence electrocardiogram models for hypertrophic cardiomyopathy and cardiac amyloidosis in competitive athletes
- Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial